September 16, 2021

Xcenda has been named a finalist for the Biosimilar Initiative of the Year in the 2021 Global Generics & Biosimilars Awards

We are proud to share that Xcenda has been named a finalist for the Biosimilar Initiative of the Year in the 2021 Global Generics & Biosimilars Awards! We were named to the shortlist for our work on the Biosimilars Resource Hub, which supports United States healthcare decision-makers by providing free centralized access to biosimilar resources to support product evaluation and formulary decision-making.

Learn more about the awards and view the shortlist of finalists here. The winners for all award categories will be announced on November 10, 2021.


Vials

FormularyDecisions

About the Biosimilars Resource Hub

Vials
The Biosimilars Resource Hub on FormularyDecisions® was launched in early 2021 and provides healthcare decision makers with free online access to US biosimilar product and pipeline information, regulatory guidance, curated articles and resources, and state-specific substitution laws.

The Biosimilars Resource Hub is a free, one-stop-shop for US biosimilar information to support formulary decision-making for biosimilar products in the United States. More than half of the biosimilars on the market have launched in the last 18 months, making resources like The Biosimilars Resource Hub a critical tool for US formulary decision-makers. With more biosimilars in the product development pipeline, the Biosimilars Resource Hub will remain an important decision-making tool in the future.
Vials

Ready to get started with FormularyDecisions?

Access evidence for thousands of products—All from one site

Join the largest online community of your peers in reviewing products in both the pre- and post-launch stages for formulary placement decisions

Join a peer community

2500+

Registered, active healthcare decision makers

Access product data

3000+

FDA-approved and pipeline products

Secure platform

24/7

Available to you on-demand